John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$244M |
| 2 |
Enphase Energy
ENPH
|
+$229M |
| 3 |
GSK
GSK
|
+$223M |
| 4 |
Accenture
ACN
|
+$209M |
| 5 |
Citigroup
C
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$294M |
| 2 |
Amazon
AMZN
|
+$272M |
| 3 |
PayPal
PYPL
|
+$271M |
| 4 |
Bank of America
BAC
|
+$225M |
| 5 |
AVGOP
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 13.7% |
| 3 | Financials | 9.76% |
| 4 | Industrials | 8.72% |
| 5 | Consumer Discretionary | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LNAI
2001
Lunai Bioworks
LNAI
$9.66M
| $253K | ﹤0.01% |
1,750
-609
| -26% | -$111K |
|
2002
Arcosa
ACA
$7.13B
| $252K | ﹤0.01% |
+4,400
| New | +$244K |
|
|
TECX
2003
Tectonic Therapeutic
TECX
$713M
| $252K | ﹤0.01% |
32,719
-6,751
| -17% | -$74.9K |
|
|
CSII
2004
DELISTED
Cardiovascular Systems, Inc.
CSII
| $252K | ﹤0.01% |
18,168
-36,149
| -67% | -$537K |
|
2005
Black Hills Corp
BKH
$5.49B
| $249K | ﹤0.01% |
3,671
-4,300
| -54% | -$322K |
|
2006
Varex Imaging
VREX
$781M
| $249K | ﹤0.01% |
11,800
-12,703
| -52% | -$278K |
|
2007
Sprinklr
CXM
$1.74B
| $248K | ﹤0.01% |
+26,895
| New | +$303K |
|
2008
VirnetX Holding Corp
VHC
$52.1M
| $247K | ﹤0.01% |
10,546
-1,357
| -11% | -$43.8K |
|
2009
CDW
CDW
$16.6B
| $246K | ﹤0.01% |
+1,577
| New | +$270K |
|
|
ITIC
2010
Investors Title Co
ITIC
$562M
| $246K | ﹤0.01% |
+1,748
| New | +$261K |
|
|
NSTD
2011
DELISTED
Northern Star Investment Corp. IV
NSTD
| $245K | ﹤0.01% |
+24,997
| New | +$246K |
|
2012
Korn Ferry
KFY
$4.35B
| $244K | ﹤0.01% |
5,200
+800
| +18% | +$47.3K |
|
2013
Ocugen
OCGN
$461M
| $244K | ﹤0.01% |
+137,277
| New | +$342K |
|
|
CNH
2014
CNH Industrial
CNH
$18.9B
| $244K | ﹤0.01% |
21,822
-52,400
| -71% | -$631K |
|
2015
CorVel
CRVL
$3.6B
| $243K | ﹤0.01% |
+5,262
| New | +$273K |
|
2016
Globus Medical
GMED
$11.3B
| $243K | ﹤0.01% |
+4,079
| New | +$246K |
|
2017
Larimar Therapeutics
LRMR
$421M
| $243K | ﹤0.01% |
75,942
+53,230
| +234% | +$133K |
|
2018
Rafael Holdings
RFL
$114M
| $243K | ﹤0.01% |
136,835
-44,658
| -25% | -$94.2K |
|
2019
Riskified
RSKD
$786M
| $243K | ﹤0.01% |
+61,574
| New | +$289K |
|
2020
Janus International
JBI
$696M
| $240K | ﹤0.01% |
26,900
-9,800
| -27% | -$99.3K |
|
2021
National Fuel Gas
NFG
$7.84B
| $240K | ﹤0.01% |
+3,900
| New | +$269K |
|
|
INST
2022
DELISTED
Instructure Holdings, Inc.
INST
| $239K | ﹤0.01% |
+10,740
| New | +$251K |
|
2023
Global X Cloud Computing ETF
CLOU
$368M
| $238K | ﹤0.01% |
14,940
-73,960
| -83% | -$1.28M |
|
|
DRRX
2024
DELISTED
DURECT Corp
DRRX
| $237K | ﹤0.01% |
40,956
-3,611
| -8% | -$22K |
|
|
SSAA
2025
DELISTED
Science Strategic Acquisition Corp. Alpha Class A Common Stock
SSAA
| $237K | ﹤0.01% |
+24,000
| New | +$236K |
|
Similar funds
John Overdeck's Q3 2022 Portfolio in Review
As of Q3 2022, John Overdeck held 3,036 positions worth $29.4B, down 2.9% from $30.3B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
John Overdeck's Q3 2022 filing shows 582 new, 766 increased, 960 reduced and 600 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,198,196 shares worth $210M. The largest sale was Netflix, an estimated $294M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q3 2022 buy was Alphabet (Google) Class A: 2,198,196 shares worth $210M.
- John Overdeck added most to GSK in Q3 2022, an estimated $223M increase.
- John Overdeck's biggest Q3 2022 reduction was Netflix, cutting an estimated $294M.
- John Overdeck fully exited Bank of America in Q3 2022, selling an estimated $225M.
- John Overdeck's ten largest holdings make up 8.9% of its $29.4B portfolio in Q3 2022.
- John Overdeck opened 582 new positions and closed 600 in Q3 2022.
- John Overdeck's portfolio value fell 2.9% quarter-over-quarter to $29.4B.
Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.